# Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery

> **NCT05645809** · NA · UNKNOWN · sponsor: **Samyang Biopharmaceuticals Corporation** · enrollment: 98 (estimated)

## Conditions studied

- Laparoscopic Hysterectomy

## Interventions

- **DEVICE:** MONOFIX® PGCL
- **DEVICE:** Quill Monoderm™

## Key facts

- **NCT ID:** NCT05645809
- **Lead sponsor:** Samyang Biopharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-03
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-09-30
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2022-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645809, "Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05645809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*